Longevity Risk

A heightened awareness of the aging population means that all parties have to closely track and monitor their longevity assumptions and developments. This ensures appropriate longevity bases are used in pricing and reserving for longevity risk. It has also spurred a trend to de-risk, bringing new entrants to the bulk annuity and pension buy-out market, including insurance and reinsurance companies and investment banks, as well as increasing the appetite for longevity risk only deals such as longevity swaps. Longevity risk is fast emerging as a financial sector in its own right and this new book from Risk Books, provides cutting edge practitioner insight and research around longevity risk in a practical and accessible way. Edited by Emma McWilliam and drawing on the views of leading industry experts from insurance, reinsurance, capital markets and legal backgrounds Longevity Risk provides a 360° view of the market. Contributors include: Edouard Debonneuil, Lise He, Jessica Mosher, Nathalie Weiss (Groupe AXA) Ed Collinge, Joseph Lu (Legal & General Group) Eli Friedwald, Jason Hurley, Greg Becker (RGA UK Services Limited) Bridget Browne (Partner Reinsurance limited) Stephen Makin (Stephen Makin Consulting Limited) Robert Bugg, Farzana Ismail, Philip Simpson, Nick Dumbreck (Milliman) Norman Peard, James Morris (Credit Suisse) Gavin Jones, Alison McKie, Nick Ketley (Swiss Re) Guy Coughlan (JP Morgan) Paul Sweeting (University of Kent) Jennifer Donohue (Cadwalader, Wickersham & Taft LLP) Longevity Risk presents methods to price and measure longevity risk and ways to hedge/de-risk through a range of traditional insurance, reinsurance and innovative capital market solutions. A key feature of the book is a series of practical case studies that will enable you to apply the new knowledge you learn in a practical way. There are 5 main sections encompassing all the major aspects of this growing market to give you a total understanding of this emerging risk. Section I Setting the Scene provides key background information and facts on the issue and opportunity. Section II Pricing Longevity Risk - considers the setting of best estimate base mortality assumptions and alternative longevity projections. Section III - Reserving and Capital Requirements: - the impact of Solvency II and economic capital modeling for longevity risk. Section IV Risk Management and De-Risking Solutions: - wider considerations will be given to the natural offset of pandemic risk and legal considerations of transactions. Section V - Capital Market Developments: - the desirable features, different roles of players, longevity indices and capital market structures. In order to take advantage of this fast emerging market and the opportunities presenting themselves Longevity Risk is regarded as key reading for (re)insurance company professionals, finance managers/directors, investors, actuaries, corporate sponsors, trustees of pension schemes, investment bankers and graduate students/academics.

Emma is a senior consulting actuary at Milliman, London. She has more than fifteen years of experience in the insurance industry and has worked internationally advising insurance and reinsurance companies, including multi-nationals on assignments in the UK, US, Australia, Singapore, Switzerland, Germany, Netherlands, France and Belgium. She has significant experience in the area of annuities and longevity risk having advised market participants on acquiring blocks of annuity business, setting longevity pricing bases and terms of trade, including base mortality table selection, improvement factors, credibility approach, underwriting factors, experience studies and medical advancement considerations. She has also reviewed mortality pricing bases for annuity longevity transactions, undertaken strategic assignments to identify life insurance securitisation opportunities and worked with investment banks on the development of a longevity bond and swap structures and reviewed longevity risk structures for transferring this risk to the capital markets. She is a regular presenter at industry conferences around longevity risk and capital markets. She has also co-authored a number of publications and articles, primarily covering the areas of longevity risk and prior to this IFRS.